Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy

Detalles Bibliográficos
Autores principales: Ling, Feng, Xu, Shengen, Li, Xiaochen, Sun, Xingwang, Long, Wenbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969661/
https://www.ncbi.nlm.nih.gov/pubmed/36849899
http://dx.doi.org/10.1186/s12885-023-10666-z
_version_ 1784897777935843328
author Ling, Feng
Xu, Shengen
Li, Xiaochen
Sun, Xingwang
Long, Wenbo
author_facet Ling, Feng
Xu, Shengen
Li, Xiaochen
Sun, Xingwang
Long, Wenbo
author_sort Ling, Feng
collection PubMed
description
format Online
Article
Text
id pubmed-9969661
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99696612023-02-28 Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy Ling, Feng Xu, Shengen Li, Xiaochen Sun, Xingwang Long, Wenbo BMC Cancer Correction BioMed Central 2023-02-27 /pmc/articles/PMC9969661/ /pubmed/36849899 http://dx.doi.org/10.1186/s12885-023-10666-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Ling, Feng
Xu, Shengen
Li, Xiaochen
Sun, Xingwang
Long, Wenbo
Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy
title Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy
title_full Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy
title_fullStr Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy
title_full_unstemmed Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy
title_short Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy
title_sort correction: cytoplasmic poly(a)-binding protein 1 (pabpc1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969661/
https://www.ncbi.nlm.nih.gov/pubmed/36849899
http://dx.doi.org/10.1186/s12885-023-10666-z
work_keys_str_mv AT lingfeng correctioncytoplasmicpolyabindingprotein1pabpc1isaprognosticbiomarkertopredictsurvivalinnasopharyngealcarcinomaregardlessofchemoradiotherapy
AT xushengen correctioncytoplasmicpolyabindingprotein1pabpc1isaprognosticbiomarkertopredictsurvivalinnasopharyngealcarcinomaregardlessofchemoradiotherapy
AT lixiaochen correctioncytoplasmicpolyabindingprotein1pabpc1isaprognosticbiomarkertopredictsurvivalinnasopharyngealcarcinomaregardlessofchemoradiotherapy
AT sunxingwang correctioncytoplasmicpolyabindingprotein1pabpc1isaprognosticbiomarkertopredictsurvivalinnasopharyngealcarcinomaregardlessofchemoradiotherapy
AT longwenbo correctioncytoplasmicpolyabindingprotein1pabpc1isaprognosticbiomarkertopredictsurvivalinnasopharyngealcarcinomaregardlessofchemoradiotherapy

Ejemplares similares